Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Singer Lisa Marie Presley's daughter Riley Keough is shedding new light on some of the health challenges her mother faced ...

Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

(THE CONVERSATION) In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...